Printed from acutecaretesting.org
Articles by Robert F. Moran
Showing articles by "Robert F. Moran"
Article
June 2020
TEST 100 years of blood gas and acid base analysis in clinical medicine
Summey Text Summey Te Summey Te Summey Te Summey Te Summey TeSummey Te Summey TeSummey Te Summey Te v Summey Te Summey TeSummey Tev v v Summey Te Summey Te Summey Te Summey Te v v v vSummey TeSummey TeSummey TeSummey TeSummey TeSummey Te Summey TeSummey TeSummey Te v
Blood gases/acid-base
Article
June 2018
Clarifying the confusion of GFRs, creatinine, and cystatin C
Because measurements of GFR are tedious, estimated GFRs based on creatinine or cystatin C are widely used for assessing kidney function. Both measured GFRs and the Staging System for CKD based on GFR have analytical and clinical shortcomings. The advantages of serum creatinine and cystatin C, and eGFR will be...
Creatinine/urea
Kidneys/fluids
Article
October 2014
Point-of-care cardiac markers in the Emergency Department are safe, reduce admissions and do not impact on the 4-hour target
Barnsley Emergency Department (ED), which recruited patients into the RATPAC trial, initiated a point-of-care (POC) pathway for low-risk chest pain patients from December 2011.
All patients who underwent POC testing for chest pain between December 2011 and July 2012 were identified. Patient notes were then examined...
Cardiac markers
Point-of-care testing
Process optimization
Troponins
Article
October 2014
POCT in emergency rooms: One key factor for process streamlining with Lean Management
In the past years, emergency rooms (ER) all over Germany, especially those of maximum-care hospitals, have been faced with an increasing number of patients. This is caused by a variety of factors, including demographic changes, inflexible ambulant services and an overreaching demand for healthcare services.
ER...
Cardiac markers
Point-of-care testing
Process optimization
Hemoglobins
D-dimer
Troponins
CRP
Article
January 2014
The Role of Cardiac Biomarkers in the Diagnosis and Management of Patients Presenting with Suspected Acute Coronary Syndrome
Reprinted from Ann Lab Med 2013 Sep; 33(5):309-18.
Christenson E, Christenson RH: "The role of cardiac biomarkers in the diagnosis and management of patients presenting with suspected acute coronary syndrome".
Myocardial infarction (MI) is the leading cause of death in the developed world. Biomarkers have an...
Cardiac markers
Troponins
Article
April 2013
POCT of NT-proBNP in patients with renal disease
Point of care (POC) testing has become an important part of nephrological care. In cases of acute renal failure, POC is indispensible in deciding the need for dialysis, but is also essential in the management of patients on regular dialysis.
For example, hyperhydration, cardiovascular adverse events and inflammation...
Point-of-care testing
Cardiac markers
Glucose
Hemoglobins
D-dimer
Troponins
CRP
Natriuretic peptide
Kidneys/fluids
Article
October 2012
100 years of blood gas and acid base analysis in clinical medicine
The term acidosis was first mentioned in the medical literature in 1898 in connection with the description of diabetic ketoacidosis. Alkalosis was first used in human medicine in 1922 by the English physiologist J. S. Haldane; it had been used in veterinary medicine somewhat earlier.
In 1870, the Norwegians C. M....
Blood gases/acid-base
Glucose
Lactate
Hemoglobins
Article
July 2012
Effect of small air bubbles on changes in blood pO2 and blood gas parameters: calculated vs. measured effects
When collecting blood for blood gas analysis, it is important to remove air bubbles from syringes to avoid erroneous results, especially for pO2, with a number of factors affecting the potential magnitude of the interference to pO2 by air bubbles.
In this study, we calculate the expected theoretical changes in pO2...
Blood gases/acid-base
Preanalytical phase
Article
January 2012
POCT in the ED - relevant clinical and economical advantages
In the ED, 25 % of patients with angina pectoris with suspected AMI are wrongly diagnosed (no cardiac involvement). As a result, the patient risks are increased and resources are wasted.
We investigated the effect of point-of-care testing (POCT) on ED processes, resource needs, patient risks and overall costs.
POCT...
Cardiac markers
Process optimization
Point-of-care testing
Lactate
Creatinine/urea
D-dimer
Troponins
Natriuretic peptide
Article
October 2011
Choosing cut-offs for NT-proBNP
Various guidelines and recommendations are available for the use of natriuretic peptides in the diagnosis of heart failure.
As it is known that old age may lead to higher natriuretic peptide values in the absence of heart failure, it is relevant to decide whether to use age-dependent reference intervals for clinical...
Cardiac markers
Natriuretic peptide
